Answer
The most frequently reported adverse reaction to vericiguat in the VICTORIA study was hypotension, reported in 16.4% of vericiguat-treated patients.
Sources for this answer
- Verquvo 2.5 mg film-coated tabletsBayer plc · emc · SmPC §4.8 Undesirable effects · Version 2Document updated
Sources checked